Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/04/2003CA2485648A1 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003CA2485169A1 Peptide derivatives, and their use for the synthesis of silicon-based composite materials
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2484010A1 Pna probes, probe sets, methods and kits pertaining to the determination of listeria
12/04/2003CA2483201A1 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003CA2478833A1 Anti-.alpha.v.beta.6 antibodies
12/03/2003EP1367436A1 Coating fluid for imaging element comprising solubilized ossein gelatin and hardener
12/03/2003EP1367397A1 Diagnostics and therapeutics for diseases associated with somatostatin receptor 1 (SSTR1)
12/03/2003EP1367128A1 Genetically engineered vaccine strain
12/03/2003EP1367126A1 Novel vectors for animal cells and utilization thereof
12/03/2003EP1367124A1 5' ests for secreted proteins expressed in muscle and other mesodermal tissues
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1367121A2 Process for immobilizing polypeptides via the carboxyl group of the C-terminus
12/03/2003EP1367066A2 Succinylated fish gelatin
12/03/2003EP1367065A1 Acid soluble proteins from micellar casein
12/03/2003EP1367064A1 Inhibitors of proteins from the Rho-GEF family
12/03/2003EP1366773A1 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
12/03/2003EP1366771A2 Use of the neurotoxic compnent of botulinum toxins as a medicament
12/03/2003EP1366770A2 Use of botulinum toxin for treating muscle-associated pain
12/03/2003EP1366769A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing extracellular matrix receptor-ligand interaction
12/03/2003EP1366455A2 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2003EP1366368A2 Alpha synuclein aggregation assays
12/03/2003EP1366366A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/03/2003EP1366176A2 Synthetic genes and bacterial plasmids devoid of cpg
12/03/2003EP1366175A2 Multifunctional protease inhibitors and their use in treatment of disease
12/03/2003EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
12/03/2003EP1366171A2 Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells
12/03/2003EP1366169A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
12/03/2003EP1366168A1 Plant-derived molecules and genetic sequences encoding same and uses therefor
12/03/2003EP1366167A2 Biological organism for preparing pharmaceutical compositions for treating mammals
12/03/2003EP1366166A2 Molecules for diagnostics and therapeutics
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366164A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals
12/03/2003EP1366163A2 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366160A2 Mini-dystrophin nucleic acid and peptide sequences
12/03/2003EP1366159A2 Lymphoma associated molecules and uses therefor
12/03/2003EP1366158A2 Trp8, trp9 and trp10, markers for cancer
12/03/2003EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer
12/03/2003EP1366156A2 Osteolevin gene polymorphisms
12/03/2003EP1366155A1 Methods and agents for modifying human angiogenesis
12/03/2003EP1366153A2 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366147A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27
12/03/2003EP1366079A2 Nuclear hormone receptor ligand binding domain
12/03/2003EP1366078A2 Ige receptor antagonists
12/03/2003EP1366077A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
12/03/2003EP1366076A2 Compounds and methods for modulating desmosomal cadherin-mediated functions
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1366074A2 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity
12/03/2003EP1366073A2 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof
12/03/2003EP1366072A2 Ets-transcription factor related compound specific promoter and transactivators thereof
12/03/2003EP1366071A2 Dna-sequences, which code for an apoptosis signal transduction protein
12/03/2003EP1366070A2 Cotton event pv-ghgt07(1445) and compositions and methods for detection thereof
12/03/2003EP1366069A2 Histone acetyltransferase inhibitors and their use as insecticides
12/03/2003EP1366068A1 Poynucleotide and polypeptide from group b streptococcus and use thereof for the preparation of a vaccine
12/03/2003EP1366067A2 Expression technology for proteins containing a hybrid isotype antibody moiety
12/03/2003EP1366062A2 Efficient recovery of correctly refolded proteins
12/03/2003EP1366060A2 Methods of purification and recovery of interferon-beta
12/03/2003EP1366059A2 Methods and compositions for modulating gluconeogenesis using pgc-1
12/03/2003EP1365813A2 Ascorbic acid analogs for metalloradiopharmaceuticals
12/03/2003EP1365805A2 Novel targeted compositions for diagnostic and therapeutic use
12/03/2003EP1365804A2 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
12/03/2003EP1365801A1 Methods and materials relating to fibulin-like polypeptides and polynucleotides
12/03/2003EP1365799A1 A noval vaccine formulation consisting of dna vaccine inactivated virus
12/03/2003EP1365793A2 Treatment of inflammatory bowel disease using growth factors
12/03/2003EP1365786A2 Accessory cholera enterotoxin and analogs thereof as activators of calcium dependent chloride channel
12/03/2003EP1365785A2 Use of ciliary neurotrophic factor
12/03/2003EP1365774A2 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/03/2003EP1365753A2 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
12/03/2003EP1365726A2 Method for evaluating therapeutic efficacy
12/03/2003EP1365645A2 Transgenic mice containing targeted gene disruptions
12/03/2003EP1165184B1 Estrogen receptor-beta antagonism and bone diseases
12/03/2003EP1064306B1 Nephrin gene and protein
12/03/2003EP0952982B1 Novel hepatitis b inhibitors
12/03/2003EP0874624B1 Hyaluronic acid receptors binding agents and their use for treating tumors or restenosis
12/03/2003EP0832095B1 A method of cross-linking amino acid-containing polymers using photoactivatable chemical cross-linkers
12/03/2003EP0776367B8 Dna encoding turkey hypothalamic vasoactive intestinal peptide
12/03/2003EP0772466B1 Compositions and methods for a bioartificial extracellular matrix
12/03/2003EP0767666B1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
12/03/2003EP0765393B1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator
12/03/2003EP0724644B1 Dna encoding 1,3-beta-d glucan synthase subunits
12/03/2003EP0631629B1 Fungus-responsive chimaeric gene
12/03/2003EP0625573B1 Novel dna, polypeptide coded for thereby, and method of detecting both
12/03/2003CN1460181A Nucleic acid sequences and protein involved in cellular senescence
12/03/2003CN1460111A HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines
12/03/2003CN1460110A Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
12/03/2003CN1460024A Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
12/03/2003CN1460023A Polymer-modified bioactive sythetic chemokines, and method for their mfg. and use
12/03/2003CN1459506A Recombination expression and application of Chinese prawn antibacterial peptide gene
12/03/2003CN1459503A Jiulian agglutinin protein and its code sequence
12/03/2003CN1459459A Preparation and assaying of peptide dextran possessing detectable oral absorption immune regulation of rainbow conk
12/03/2003CN1459458A Testes spermatogenous cell die related gene
12/03/2003CN1459457A Method of producing human forcing erythrogenin using transgene animal mammary gland
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/03/2003CN1129795C Methods of typing hepatitis C virus and reagents for use therein
12/03/2003CN1129666C Human tissue inhibitor of metalloproteinase -4
12/03/2003CN1129609C Flocculation clarification ultrafiltration concentration process of producing composite immunoreactive protein
12/03/2003CN1129608C Method and apparatus for preparing acellular red blood cell substitute
1 ... 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 ... 2916